CBGA and CBDA Display Potential to Combat COVID-19
According to a study conducted by the team of scientists from Oregon’s Health & Science University, CBGA (cannabigerolic acid) and CBDA (cannabidiolic acid) — the two compounds found in hemp — could potentially turn the tide in the ongoing pandemic.
The study was led by Richard van Breemen, who believes the mentioned compounds have the potential to perhaps even treat infections caused by SARS-CoV-2.
Namely, the results of their study show the mentioned compounds have the ability to bind to COVID-19 spike proteins, thus preventing them from entering human cells.
Van Breemen added that the results also show CBDA and CBGA were effective against two variants of COVID-19 — the B.1.1.7 and the B.1.351.
And although it’s still too early to claim a victory over the invisible enemy, Van Breemen believes that CBDA and CBGA could be used in the future development of drugs that either prevent or treat COVID-19.
So far, we know that the mentioned compounds are safe for humans.
More precisely, CBDA is hemp’s non-psychoactive compound that converts to CBD when exposed to heat. And unlike most cannabinoids that bind to CB1 or CB2 receptors, CBDA inhibits the cyclooxygenase-2 enzyme. Meaning, CBDA can help with inflammation and pain.
On the other hand, CBGA is the raw form of CBG. As a result, it can also be called a foundational molecule that is responsible for the formation of other cannabinoids. This compound is mainly used for therapeutic purposes.
Nevertheless, despite the promising news, we’re still a long way from any practical application as of now.